ALNYLAM PHARMACEUTICALS, INC. Annual Nonoperating Income (Expense) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Alnylam Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2023.
  • Alnylam Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$31.8M, a 49.7% increase year-over-year.
  • Alnylam Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$133M, a 10.4% increase year-over-year.
  • Alnylam Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was -$151M, a 55.7% increase from 2022.
  • Alnylam Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was -$342M, a 138% decline from 2021.
  • Alnylam Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was -$143M, a 428% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$151M +$191M +55.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 -$342M -$198M -138% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 -$143M -$116M -428% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 -$27.2M -$81.3M -150% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $54.2M +$179K +0.33% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-10
2018 $54M +$44.8M +486% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-11
2017 $9.21M -$5.27M -36.4% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-13
2016 $14.5M +$8.54M +144% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-14
2015 $5.94M +$1.56M +35.6% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-15
2014 $4.38M +$3.35M +328% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-15
2013 $1.02M -$11.8M -92.1% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-12
2012 $12.9M +$15.7M Jan 1, 2012 Dec 31, 2012 10-K 2015-02-13
2011 -$2.83M -$3.9M -365% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-20
2010 $1.07M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.